“Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S18. doi:10.25251/skin.2.supp.18.